Document:

Exhibit 10.41

 

NOTE PURCHASE AGREEMENT

 

April 12, 2012

 

Adcare Health Systems, Inc.

5057 Troy Road

Springfield, Ohio 45502

 

Attn:  Boyd P. Gentry

Chief Executive Officer

 

Dear Ladies and Gentlemen:

 

The undersigned (the “Note Purchaser”) offers to enter into this Note Purchase Agreement (this “Note Purchase Agreement”) with Adcare Health Systems, Inc., an Ohio corporation (the “Company”), which, upon acceptance of this offer by the Company, will be binding upon the Company and the Note Purchaser. This offer is made subject to written acceptance hereof by the Company at or before 6:00 P.M., Eastern Time, on the date hereof, unless extended by agreement by the parties.

 

SECTION 1. PURCHASE AND SALE OF THE NOTE

 

Based upon the terms and conditions and upon the representations herein set forth, the Note Purchaser hereby agrees to purchase from the Company, and the Company hereby agrees to sell and deliver to the Note Purchaser, a single promissory note (the “Note”), which will, except as otherwise agreed to in writing by the Note Purchaser and the Company, or as otherwise provided therein, (i) mature on October 1, 2012 (the “Stated Maturity Date”), (ii) bear interest at the rate of ten percent (10.00%) per annum, (iii) be substantially in the form of Exhibit A, attached hereto and made a part hereof, and (iv) be in a principal amount not in excess of $1,500,000.

 

SECTION 2. DELIVERY OF THE NOTE AND CLOSING

 

At 10:00 a.m. (Eastern Time) on April 27, 2012, or at such other time or on such earlier or later date as to which we may mutually agree (the “Closing Date”), the Company will cause the Note to be delivered to the Note Purchaser, at the offices of the Note Purchaser, at 766 Shrewsbury Avenue, Tinton Falls, New Jersey. On the Closing Date, the Note Purchaser will accept delivery of the Note, and will pay the Company a purchase price therefor in an amount equal to ninety-six percent (96%) of the face amount of the Note, in federal or other immediately available funds by wire.

 

 

SECTION 3. DISCLOSURE MEMORANDUM

 

By its acceptance of this Note Purchase Agreement, the Company authorizes the Note Purchaser to rely upon the Confidential Disclosure Memorandum dated the date hereof (the “Confidential Disclosure Memorandum”), relating to the sale and purchase of the Note, and hereby deems the Confidential Disclosure Memorandum final. All terms defined in the Confidential Disclosure Memorandum (and not otherwise defined herein) shall have their respective defined meanings when used herein.

 

SECTION 4. REPRESENTATIONS AND AGREEMENTS OF THE NOTE PURCHASER

 

The Note Purchaser represents to and agrees with the Company that, as of the date hereof:

 

(a) The Note Purchaser is a limited liability company, duly organized, validly existing and in good standing under the laws of the Commonwealth of Pennsylvania, having all requisite power and authority to carry on its business as now constituted.

 

(b) The Note Purchaser has received all information with respect to the Company that it has requested from the Company in order to purchase the Note.

 

(c) The documents relating to the purchase of the Note have been reviewed by the Note Purchaser and contain terms acceptable to, and agreed to by, the Note Purchaser.

 

(d) The Note Purchaser has the requisite authority to enter into this Note Purchase Agreement. This Note Purchase Agreement has been duly executed and delivered by the Note Purchaser and, assuming the due authorization, execution and delivery by the Company, is the binding and valid obligation of the Note Purchaser, enforceable in accordance with its terms, except that the enforceability hereof may be limited by applicable bankruptcy, insolvency, moratorium or other similar laws or equitable principles affecting creditors’ rights or remedies generally.

 

SECTION 5. REPRESENTATIONS, WARRANTIES, COVENANTS OF THE COMPANY

 

The Company represents to and agrees with the Note Purchaser that, as of the date hereof and the date of the Closing:

 

(a)        Disclosure Memorandum. The statements and information in the Confidential Disclosure Memorandum, insofar as the same relate to the Company, as of its date were true, correct and complete in all material respects, and such information and statements in the Confidential Disclosure Memorandum do not include any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make such statements and information, in light of the circumstances under which they are, or were made, not misleading.

 

2

 

(b)        Existence. The Company is, and will continue to be, a corporation, duly organized, validly existing, in good standing under the laws of the State of Ohio, with full power and authority to own its properties and conduct its business as and where the same are now owned and conducted.

 

(c)        Authority. The Company has the requisite power and authority to enter into and consummate all of the transactions contemplated on its part by this Note Purchase Agreement, the Confidential Disclosure Memorandum, the Note, and all other documents required by the terms hereof or of any thereof to be executed and delivered by the Company (collectively, the “Transaction Documents”).

 

(d)        Due Execution and Delivery of Documents. This Note Purchase Agreement has been duly executed and delivered by the Company and, when executed and delivered by the Note Purchaser, will be, and the other Transaction Documents, when executed and delivered by the Company (if applicable) and the other parties thereto, will be, legal, valid and binding agreements of the Company, enforceable in accordance with their terms, subject as to enforcement of remedies to applicable bankruptcy, insolvency, reorganization, moratorium and similar laws in effect from time to time affecting the rights of creditors generally and to the availability of equitable relief.

 

(e)        No Conflicts. The acceptance, execution and delivery of this Note Purchase Agreement and the other Transaction Documents, and the compliance with the provisions hereof and thereof do not and will not violate or conflict with (in any material respect) any resolution adopted by the Company’s board of directors, to the knowledge of the Company, do not and will not conflict with or violate, or result in or constitute a material breach of or default under, any indenture, mortgage, deed of trust, guaranty, lease, agreement or other instrument to which the Company is a party or by which the Company or any of its property is bound, which would have a materially adverse effect on the transactions contemplated by this Note Purchase Agreement, or, to the knowledge of the Company, conflict with or violate any provision of any law, administrative rule or regulation, or any judgment, order or decree to which the Company or any of its property is subject.

 

(f)         Compliance with Law. Except as may otherwise be disclosed in writing to the Note Purchaser, the Company is in substantial compliance with all applicable federal, state and local laws and ordinances (including rules and regulations) that are applicable to it or its business operations and financial affairs.

 

SECTION 6. INDEMNIFICATION

 

(a)        Scope of Indemnification by the Company. The Company hereby agrees to indemnify, protect, defend and hold harmless the Note Purchaser, each member and employee thereof, and each person, if any, who controls the Note Purchaser within the meaning of Section 15 of the Securities Act of 1933, as amended, or Section 20 of the Securities Exchange Act of 1934, as amended (any such person being herein sometimes called an “Indemnified Party”), against all losses, claims, damages, liabilities or expenses, whether joint or several, to which any such Indemnified Party may become subject, under any statute or regulation at law or in 

 

3

 

equity or otherwise insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact set forth in the Confidential Disclosure Memorandum, or any amendment or supplement thereof, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or which is necessary to make the statements made therein, in light of the circumstances in which they were made, not misleading in any material respect, and will reimburse any legal or other expenses reasonably incurred by any such Indemnified Party in connection with investigating or defending any such loss, claim, damage, liability or action. Provided, however, that such indemnity shall not extend to any Indemnified Party if the loss, claim, damage or liability is caused by the gross negligence or willful misconduct of the Indemnified Party. This indemnity agreement shall not be construed as a limitation on any other liability that the Company may otherwise have to any Indemnified Party, provided that in no event shall the Company be obligated for double indemnification. And provided further, that the Company shall have no obligation of indemnification hereunder in respect of any statement made in, or omitted from, the following sections of the Confidential Disclosure Memorandum: “THE CERTIFICATES OF PARTICIPATION”, “CANTONE ASSET MANAGEMENT LLC”, or “TAX MATTERS”.

 

(b)        Procedure. An Indemnified Party shall, promptly after the receipt of notice of the commencement of any action against such Indemnified Party in respect of which indemnification may be sought against the Company, notify the Company in writing of the commencement thereof. Failure of the Indemnified Party to give such notice will reduce the liability of the Company by the amount of damages attributable to the failure of the Indemnified Party to give such notice to the Company, but the omission to notify the Company of any such action shall not relieve the Company from any liability that it may have to such Indemnified Party otherwise than under this section. In case any such action shall be brought against an Indemnified Party and such Indemnified Party shall notify the Company of the commencement thereof, the Company may, or if so requested by such Indemnified Party shall, participate therein or assume the defense thereof, with counsel satisfactory to such Indemnified Party (it being understood that, except as hereinafter provided, the Company shall not be liable for the expenses of more than one separate counsel representing the Indemnified Parties in such action), and after notice from the Company to such Indemnified Party of an election so to assume the defense thereof, the Company will not be liable to such Indemnified Party under this Section for any legal or other expenses subsequently incurred by such Indemnified Party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that unless and until the Company assumes the defense of any such action at the request of such Indemnified Party, the Indemnified Party shall have the right to participate at its own expense in the defense of any such action. If the Company shall not have employed counsel to take charge of the defense of any such action, or if an Indemnified Party shall have reasonably concluded that there may be defenses available to it or other Indemnified Parties that are different from or additional to those available to the Company (in which cases the Company shall not have the right to direct the defense of such action on behalf of such Indemnified Party) or to other Indemnified Parties, legal and other expenses, including the expenses of separate counsel incurred by such Indemnified Party shall be borne by the Company.

 

4

 

SECTION 7. CONDITIONS OF THE NOTE PURCHASER’S OBLIGATIONS

 

The Note Purchaser has entered into this Note Purchase Agreement in reliance upon the representations and agreements of the Company herein and the Performance by the Company of its obligations hereunder, both as of the date hereof and as of the Closing Date. The Note Purchaser’s obligations under this Note Purchase Agreement are and shall he subject to the following further conditions:

 

(a)   Conditions at or Prior to the Closing. Receipt by the Note Purchaser of the following documents at or prior to the Closing, all of which shall be fully executed (except for any necessary signature by the Note Purchaser):

 

(i) The Note;

 

(ii) A certificate, dated the date of the Closing, and signed by the Secretary or an Assistant Secretary of the Company, which sets forth or includes evidence satisfactory to the Note Purchaser, that: (A) the Company’s execution, delivery and Performance of its obligations under the Transaction Documents have been duly authorized by all necessary corporate action of the Company; and (B) Boyd P. Gentry has been duly authorized by all necessary corporate action of the Company to execute and deliver, on behalf of the Company, all Transaction Documents to which the Company is a party;

 

(iii) A certificate, dated the date of the Closing, signed by a duly authorized officer of the Company, and satisfactory to the Note Purchaser, to the effect that (A) each of the representations and warranties of the Company contained in this Note Purchase Agreement is true, accurate and complete on the Closing Date as if made on and as of the Closing Date, (B) each of the agreements of the Company to be complied with and each of the obligations of the Company to be performed hereunder on or prior to the Closing Date have been complied with and performed, and (C) as of the Closing Date, there has been no material adverse change in the status, business, condition or prospects (financial or otherwise) of the Company; and

 

(iv) Such additional certificates, instruments, opinions of counsel, or other documents or conditions as the Note Purchaser may reasonably request, including, but without limitation to the generality of the foregoing, a requirement that the public sales price of the Shares, on the date of Closing, be not less than $3.50.

 

(b) Failure to Satisfy Conditions. If there shall be a failure to satisfy any of the conditions to the Note Purchaser’s obligations contained in this Note Purchase Agreement, or if the Note Purchaser’s obligations shall be terminated for any reason permitted by this Note Purchase Agreement, this Note Purchase Agreement shall terminate and neither the Note Purchaser nor the Company shall have any further obligation hereunder, except as provided in Section 9 hereof.

 

5

 

SECTION 8. TERMINATION

 

The Note Purchaser shall have the right to terminate this Note Purchase Agreement by notifying the Company of its election to do so, if at the time of such notification, between the date hereof and the Closing Date, (i) there shall have occurred any new outbreak of hostilities or other unforeseen national or international calamity or crisis, the effect of such new outbreak, calamity or crisis on the financial markets of the United States being such in the reasonable judgment of the Note Purchaser as to materially adversely affect the value of the Certificates of Participation; (ii) there shall be in force a general suspension of trading on the New York Stock Exchange or minimum or maximum prices for trading shall have been fixed and be in force or maximum ranges for prices for securities shall have been required and be in force on the New York Stock Exchange, whether by virtue of a determination by that Exchange or by order of the Securities and Exchange Commission or any other governmental authority having jurisdiction; (iii) a general banking moratorium shall have been established by federal or applicable state authorities; (iv) any event, not caused by the Note Purchaser, shall have occurred or shall exist which, in the reasonable opinion of the Note Purchaser, makes untrue or incorrect, as of such time, in any material respect, any material statement or information contained in the Confidential Disclosure Memorandum or makes the Confidential Disclosure Memorandum inadequate by reason of the omission of information which should be reflected therein in order to make the statements and information contained therein not misleading as of such time; (v) a stop order, ruling, regulation or official statement by or on behalf of the Securities and Exchange Commission shall be issued or made to the effect that the issuance, offering or sale of the Certificates of Participation, or of obligations of the general character of the Certificates of Participation as contemplated hereby, is in violation of any provision of the 1933 Act, the Securities Exchange Act of 1934, as amended, or the Trust Indenture Act of 1939, as amended; or (vi) the Note Purchaser’s due diligence examination in respect of the issuance of the Certificates of Participation shall have revealed any fact or circumstance that, in the reasonable judgment of the Note Purchaser, would materially and adversely affect the value of the Certificates of Participation.

 

SECTION 9. PAYMENT OF FEES AND EXPENSES

 

(a)        Payment by the Company.

 

(i) Except as provided in Paragraph (b) below, the Company shall pay all expenses incident to the sale of the Certificates of Participation, including but without limitation, (A) the cost of the preparation (including printing, duplicating and distribution) of this Note Purchase Agreement, the Transaction Documents, or any amendment or supplement thereto, and (B) the fees of the Note Purchaser, the Note Purchaser’s Counsel, and any other counsel, experts or Consultants retained by the Company or the Note Purchaser.

 

(ii) In addition to the foregoing, on the Closing Date, the Company will pay the Note Purchaser a non-accountable miscellaneous expense allowance in the amount of $15,000.

 

6

 

(b)        Payment by Purchaser. Except as provided in the foregoing Paragraph (a), the Note Purchaser shall pay the cost of all regulatory expenses incurred by the Note Purchaser in connection with its purchase of the Note.

 

SECTION 10. NOTICES

 

Any notices or other communication to be given under this Note Purchase Agreement may be given by delivering the same in writing as follows:

 

	
As   to the Company:
    	
 
    	
Adcare   Health Systems, Inc.
    
	
 
    	
 
    	
5057   Troy Road
    
	
 
    	
 
    	
Springfield,   Ohio 45502
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Attn:   Boyd P. Gentry
    
	
 
    	
 
    	
Chief   Executive Officer
    
	
 
    	
 
    	
 
    
	
As   to the Note Purchaser:
    	
 
    	
Cantone   Asset Management LLC
    
	
 
    	
 
    	
c/o   Cantone Research, Inc.
    
	
 
    	
 
    	
766   Shrewsbury Avenue
    
	
 
    	
 
    	
Tinton   Falls, NJ 07724
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Attention:   Anthony J. Cantone
    
	
 
    	
 
    	
Managing   Member
    

 

or to such different address written notice of which is given to each of the other parties hereto.

 

SECTION 11. PARTIES IN INTEREST AND SURVIVAL OF REPRESENTATIONS

 

(a)        Parties in Interest. This Note Purchase Agreement is made solely for the benefit of the Company and the Note Purchaser (including their respective successors or assigns), and no other person, partnership, association or corporation shall acquire or have any right hereunder or by virtue hereof.

 

(b)        Survival of Representations. All representations and agreements of the Company in this Note Purchase Agreement shall remain operative and in full force and effect regardless of any investigation made by or on behalf of the Note Purchaser and all representations and agreements of the Company and the Note Purchaser shall survive the delivery of and payment for the Note.

 

7

 

SECTION 12. MISCELLANEOUS

 

(a)        Headings. The headings of the sections and Paragraphs of this Note Purchase Agreement are inserted for convenience only and shall not be deemed to be a part hereof.

 

(b)        Governing Law. This Note Purchase Agreement shall be governed by and construed in accordance with the laws of the State of New Jersey.

 

(c)        Counterparts. This Note Purchase Agreement may be executed, accepted and approved in any number of counterparts, all of which taken together shall constitute one and the same instrument, and any of the parties hereto may execute and accept or approve this Note Purchase Agreement by signing any such counterpart.

 

If you agree with the foregoing, please sign the enclosed counterpart of this Note Purchase Agreement and return it to the Note Purchaser. This Note Purchase Agreement shall become a binding agreement by and between the Company and the Note Purchaser when at least one counterpart of this Note Purchase Agreement shall have been signed by or on behalf of each of the parties hereto.

 

 

	
 
    	
Very truly yours,
    
	
 
    	
 
    
	
 
    	
CANTONE ASSET MANAGEMENT LLC
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Anthony J. Cantone
    
	
 
    	
 
    	
Anthony J. Cantone
    
	
 
    	
 
    	
Managing Member
    

 

8

 

	
Accepted as of the date first
    	
 
    
	
above written:
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
ADCARE HEALTH SYSTEMS, INC.
    	
 
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
By:
    	
/s/ Boyd P. Gentry
    	
 
    
	
 
    	
Boyd P. Gentry
    	
 
    
	
 
    	
Chief Executive Officer
    	
 
    

 

9Exhibit 10.42

 

EMPLOYMENT AGREEMENT

 

between

 

AdCare Health Systems, Inc. (the “Company”)

 

and

 

Martin D. Brew (the “Officer”)

 

This Employment Agreement (“Agreement”) is entered into August 6, 2012, to be effective July 1, 2012 (the “Effective Date”).

 

Background

 

The Company employs the Officer as of the Effective Date as Senior Vice President, Chief Financial Officer and Treasurer of the Company and desire to enter into this Agreement to reflect the terms and conditions of the Officer’s employment.

 

Statement of Agreement

 

For good and valuable consideration (including the respective obligations of the parties hereunder), the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as of the Effective Date as follows:

 

Section 1.                                            Employment.  For the purposes and upon the terms and conditions hereinafter set forth, the Company agrees to employ the Officer and the Officer accepts such employment.  The Officer’s employment shall be based in the Atlanta, Georgia greater metropolitan area, subject to business travel as necessary.  The Company shall provide the Officer with an office that is initially based in Atlanta, Georgia at its Two Buckhead Plaza, 3050 Peachtree Road location.

 

Section 2.                                            Duties.  The Officer shall be employed by the Company or one of its wholly owned subsidiaries during the Employment Term (as defined in Section 5(a)).  The Officer shall be employed by the Company as of the Effective Date, as Senior Vice President, Chief Financial Officer and Treasurer of the Company.  The Officer shall report as of the Effective Date to the Chief Executive Officer.  The Company reserves the right to change the Officer’s job position(s) or the position to which the Officer reports, but any such change shall not affect any other provision of this Agreement, including without limitation, the provisions of Section 3(a).  The Officer shall devote such time, attention and energy to the business of the Company and the performance of his duties hereunder as are necessary to properly perform his duties hereunder.  The Officer represents that his entry into, and performance of services under, this Agreement does not violate the terms of any other agreement.  The Officer also represents and warrants that he is bound by no agreement that would in any way restrict his ability to perform his duties for the Company.  The Officer will be expected to carry out his duties with the highest degree of ethical and moral standards and to comply with all terms and conditions regarding the nature and manner in carrying out his duties as may be established from time to time by the Company and set forth in its employee handbook or manual.

 

 

Section 3.                                            Compensation.

 

(a)                                  Salary.  As of the Effective Date, the Officer shall be paid a salary of $235,000 per year (the “Annual Salary”), payable in installments on the date of the Company’s regular pay periods or such other installments as the Officer and the Company from time to time mutually agree upon.  Effective January 1, 2013, the Officer’s Annual Salary shall be increased to $250,000 per year provided that he is actively employed in good standing with the Company as of that date.  Thereafter, the Annual Salary shall be reviewed at least annually by the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”) for possible increases, and if so increased, the increased amount shall thereafter be deemed to be the “Annual Salary” for all purposes under this Agreement.

 

(b)                                 Bonus.  The Officer shall be eligible to earn an annual bonus each year.  The target amount of the annual bonus, based on reasonably expected performance, shall be seventy-five percent (75%) of the Executive’s Annual Salary as of December 31st of the year for which the bonus is awarded (the “Target Bonus”).  The performance criteria for earning the bonus and the formula for determining the amount of the bonus shall be established by the CEO and Compensation Committee under the Company’s management incentive plan for executive officers.  The criteria and the formula for each year will be provided to the Officer no later than the ninetieth (90th) day of that year.  The bonus earned shall be paid in the following year as soon as feasible following the end of the year, but not later than March 30th of the following year.  The bonus for any year will be earned and accrued and payable only if the Officer is employed by the Company on the last day of the year for which the bonus is earned.

 

(c)                                  Equity Compensation.  The Officer shall be eligible to receive grants of equity compensation at the discretion of the CEO and Compensation Committee.

 

Section 4.                                            Officer Benefits; Vacation.  During the Employment Term, the Officer shall be entitled to participate in life insurance, hospitalization medical insurance, retirement, and other benefits as are presently or may hereafter be provided to other executive officers of the Company and paid vacation in accordance with the Company’s vacation policy for executive officers.  In addition to the benefits generally available to executive officers of the Company, the Company agrees to continue to pay the Officer at the rate of 100% of his Annual Salary for a period of three (3) months after the date of “Disability” and at the rate of 60% of his Annual Salary as of the date of Disability for an additional twenty-one (21) months.  For purposes of this Agreement, the term “Disability” means the inability of the Officer to perform his duties for medical reasons for a period of ninety (90) days in any three hundred sixty-five (365) day period.  In the event there is a question as to whether or not the Officer is subject to a Disability, the Board of Directors of the Company will select a qualified physician who will make the determination which will be binding on both the Officer and the Company.

 

Section 5.                                            Term of Employment.

 

(a)                                  The term of this Agreement shall begin on the Effective Date and remain in effect thereafter while the Officer is employed by the Company (the “Employment Term”).

 

2

 

(b)                                 The Company and the Officer shall at all times have the right to terminate the Officer’s employment, in the case of the Company with or without Cause, and in the case of the Officer with or without Good Reason, and in either case subject to the terms of this Agreement.  Upon termination of the Officer’s employment, the Officer shall have no obligation or duty to further serve the Company in any capacity (other than to comply with the obligations set forth in Section 6 below), nor shall the Company be under any obligation or duty to employ the Officer or provide the benefits specified in Section 4 or make any of the payments provided for in Sections 3 or 4 (except to the extent any such benefits are required to be provided by this Agreement, the applicable plan or law, or any such payments under Sections 3 or 4 have accrued prior to and remain unpaid and owing to the Officer as of the effective date of such termination).  For purposes of this Agreement, the following terms shall have the following meanings:  Resignation for “Good Reason” means the Officer’s resignation within ninety (90) days following the Company’s failure to cure a material breach of this Agreement within thirty (30) days after the Officer gives the Company written notice of such breach within ninety (90) days of the occurrence of such breach.  “Cause” means the Officer’s fraud, dishonesty, willful misconduct, or gross negligence in his performance of his duties hereunder, or the Officer’s conviction for a crime of moral turpitude, or material breach by the Officer of this Agreement which the Officer fails to cure within thirty (30) days after the Company gives the Officer written notice of such breach.

 

(c)                                  If the Officer resigns his employment for Good Reason or the Company terminates the Officer’s employment without Cause (other than due to the Officer’s Disability) the Officer or his successors and assigns shall receive the severance pay and benefits hereafter provided.  The severance pay shall be an amount equal to one (1) times Annual Salary payable in substantially equal installments at least monthly for twelve (12) months after the termination date, plus if such termination occurs within three (3) months before or twenty-four (24) months after the occurrence of a “Change in Control,” an additional half times Annual Salary plus Target Bonus payable in substantially equal installments at least monthly for six (6) months beginning immediately after twelve (12) months following the termination date.  For purposes of this Agreement, “Change in Control” means one or more sales or dispositions, within a twelve (12) month period, of assets representing a majority of the value of the assets of the Company or the acquisition (whether by purchase or through a merger or otherwise) of common stock of the Company immediately following which the holders of common stock of the Company immediately prior to such acquisition cease to own directly or indirectly common stock of the Company or its legal successor representing more than fifty percent (50%) of the voting power of the common stock of the Company or its legal successor.

 

For the period for which severance pay is paid, i.e., twelve (12) or twenty-four (24) months following termination of employment (the “Severance Period”), the Officer and his family shall be entitled to continue to be covered under all employee benefit plans of the Company under which executive officers of the Company are covered and at the same cost and under the same terms and conditions as apply to executive officers, provided, however, that if the Company is unable under applicable law or the insurer will not permit the Officer to be covered under any such plan, the Company shall pay to the Officer an amount each month during the Severance Period equal to the Company’s cost of coverage for similarly situated executive officers.  For purposes of this Agreement, termination of employment and similar terms means a termination of employment constituting a “separation from service” within the meaning of Code 

 

3

 

Section 409A.  Notwithstanding the foregoing, to the extent necessary to avoid the Officer incurring a tax under Code Section 409A, any amount that is otherwise due within six (6) months following termination of employment shall be delayed until six months after termination of employment.  The provisions contained in this Section shall survive the termination of the Officer’s employment.

 

Section 6.                                            Certain Officer Covenants.  The Officer expressly covenants and agrees to and with the Company as hereinafter set forth in this Section 6.

 

(a)                                  Non-Competition.  During the Employment Term, and in the event that the Officer’s employment is voluntarily terminated by the Officer other than for Good Reason or is terminated by the Company for Cause, then for a period of twelve (12) months after the date of termination, the Officer shall not within the Area, directly or indirectly, acting alone or with others, on behalf of a competitor of the Company undertake to perform executive management responsibilities similar to those the Officer provides for the Company during the last twenty-four (24) months of his employment with the Company.  For purposes of this Agreement “Area” shall be defined as any state in which any skilled nursing facility or business office owned or operated by the Company as of the date of the termination of this Agreement.  The foregoing restrictions shall not, however, prohibit the Officer from performing services for a division or business unit of a competitor of the Company if such division or business unit does not provide goods or services competitive with those offered by the Company.  Notwithstanding anything herein to the contrary, the provisions of this Section shall not prohibit the Officer from acquiring less than 1% of the securities of any corporation which competes with the Company and whose shares are regularly traded on a nationally recognized stock exchange or over-the-counter market.

 

(b)                                 Prohibition Against Hiring Employees.  During the Employment Term and for a period of twelve (12) months after the date of termination, regardless of the reason for termination, the Officer shall not directly or indirectly solicit for employment, or directly or indirectly assist others in soliciting for employment, any person employed by the Company whom the Officer managed or supervised, or with whom the Officer worked directly, during the then last twelve (12) months of the Officer’s termination of employment, whether or not such person is a full-time or part-time employee of the Company.

 

(c)                                  Confidential Information.  The Officer shall receive and hold all Confidential Information and Trade Secrets in trust for the Company and in the strictest confidence.  Except to the extent required in the performance of his duties hereunder, the Officer shall not at any time while he is employed by the Company or after termination of his employment, directly or indirectly, use, disclose, disseminate or otherwise publish “Confidential Information” or Trade Secrets.  For purposes of this Agreement, the term “Confidential Information” means data and information relating to the business of the Company (whether constituting a Trade Secret or not) which is or has been disclosed to the Officer or of which the Officer became aware as a consequence of or through his relationship with Company and which has value to the Company and is not generally known to the Company’s competitors.  Confidential Information shall include, without limitation, trade secrets, methods of operation, names of customers, price lists, financial information, personnel data and similar information, but shall not include any data or information which has been voluntarily disclosed to the public by the Company (except where such disclosure has been made by the Officer without 

 

4

 

authorization) or that has been independently developed and disclosed by others, or otherwise has entered the public domain through lawful means.  “Trade Secrets” means information of the Company, without regard to form, including, but not limited to, technical or nontechnical data, formulas, patterns, compilations, programs, devices, methods, techniques, drawings, processes, financial data, financial plans, product or service plans or lists of actual or potential customers or suppliers which is not commonly known by or available to the public and which information (i) derives economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use; and (ii) is the subject of efforts that are reasonable under the circumstances to maintain its secrecy.  The restrictions on use and disclosure of Confidential Information shall survive following the Officer’s termination of employment for so long as the information remains Confidential Information as defined by this Agreement.  The restrictions on use and disclosure of Trade Secrets shall survive following the Officer’s termination of employment for so long as the information is a trade secret under applicable law.

 

(d)                                 Return of Information.  Upon termination of the Officer’s employment for whatever reason, the Officer shall return to or leave with the Company, without making or retaining copies thereof, all documents, records, notebooks and similar repositories containing Confidential Information.

 

(e)                                  Reasonableness of Covenants.  The Officer has carefully considered the nature and extent of the restrictions upon him and the rights and remedies conferred upon the Company under this Section 6, and hereby acknowledges and agrees that, in light of his position, the information to which he will be privy, and the nature of the business, the restrictions are reasonable in time and territory, are designed to eliminate unfair competition to the Company, are fully required to protect the Company’s legitimate interests, and do not confer a benefit upon the Company disproportionate to any detriment to the Officer.

 

If the Officer breaches any of the agreements contained in this Section 6, then, in addition to any other rights or remedies which the Company may have, the Company shall have the right to an accounting and repayment of all profits or other benefits directly realized as a result of any such breach, to collect any damages caused by such breach in addition to those specifically listed herein, and to enforce any legal or equitable remedy (including injunctive relief) that it may have against the Officer to prevent further injury to the Company resulting from such breach.

 

The Officer acknowledges that any breach of the agreements contained in this Section could cause irreparable harm to the Company.  The Officer acknowledges that damages in the event of Officer’s breach of this Agreement will be difficult, if not impossible, to ascertain and therefore it is agreed that the Company, in addition to, and without limiting any other remedy or right it may have under this Agreement or the law, will have the right to an injunction enjoining any such breach.  The Officer agrees to reimburse the Company for all costs and expenses, including reasonable attorney’s fees, incurred by the Company because of any breach of this provision, but only in the event that the Officer fails to cure such breach, within ten (10) days after being provided written notice thereof by the Company.

 

All covenants and provisions contained in Section 6 shall survive the termination of the Officer’s employment, regardless of the reason of such termination.

 

5

 

The Officer acknowledges that the Company recommends that the Officer review this Agreement with his own legal counsel prior to signing this Agreement and the Officer confirms that the Officer has had ample opportunity to do so.

 

Section 7.                                            Notices.  Any notice or other communication required or desired to be given hereunder shall be in writing and shall be deemed duly given when personally delivered or when deposited in the United States mail, first class postage prepaid, properly addressed to the parties at their respective addresses below or such addresses as shall be given by notice of any party.

 

	
The   Company:
    	
Chief   Executive Officer
    
	
 
    	
AdCare   Health Systems, Inc.
    
	
 
    	
Two   Buckhead Plaza
    
	
 
    	
3050   Peachtree Road NW
    
	
 
    	
Suite 355
    
	
 
    	
Atlanta,   GA 30305
    
	
 
    	
 
    
	
The   Officer:
    	
The   most recent address that the Company has on file.
    

 

Section 8.                                            Actions by the Company.  Any determination, consent, waiver, agreement, or other action under or with respect to this Agreement and its implementation of or by the Company shall not be deemed made, taken or effected hereunder unless made, taken or effected in a writing signed by a duly authorized officer of the Company.

 

Section 9.                                            Waiver; Remedies Cumulative.  No waiver of any right or option hereunder by any party shall operate as a waiver of any other right or option, or the same right or option as respects any subsequent occasion for its exercise, or of any legal remedy.  No waiver by any party of any breach of this Agreement or of any agreement or covenant contained herein shall be held to constitute a waiver of any other breach or a continuation of the same breach.  All remedies provided by this Agreement are in addition to all other remedies by it or the law provided.

 

Section 10.                                      Assignment.  This Agreement shall be binding upon and inure to the benefit of the legal successors of the Company.  Neither this Agreement nor any rights hereunder shall be assignable and any such purported assignment by his shall be void and of no force or effect; provided, however, that in the event of the Officer’s death, any amounts that are unpaid and owing to the Officer or rights that are exercisable by the Officer shall be paid to or exercisable by his estate.

 

Section 11.                                      Applicable Law.  This Agreement shall be governed and construed in accordance with the laws of the State of Georgia.  Any action for breach or to enforce the terms of this Agreement, or in any way arising out of or related to Officer’s employment with the company or this Agreement, including without limitation the covenants and provisions contained in Section 6, shall be brought in the Superior Court of Fulton County, Georgia or in a federal court sitting in Atlanta, Georgia, and the parties hereto each consent to jurisdiction and venue in such courts.

 

6

 

Section 12.                                      Indemnification.  The Company shall indemnify the Officer for his actions and omissions as an officer and provide for advancement of expenses in connection therewith to the maximum extent permitted by its state of incorporation, but not for the Officer’s gross negligence or willful misconduct.  The Company shall maintain, during the Employment Term and for at least three (3) years thereafter, an adequate officer’s liability policy covering the Officer for actions and omissions during the Employment Term.

 

Section 13.                                      Severability and Judicial Modification.  The parties agree that each provision of this Agreement is separate, distinct and severable from the other remaining provisions of this Agreement, and that the invalidity or unenforceability of any Agreement provision shall not effect the validity and unenforceability of any other provision or provisions of this Agreement.  Further, if any provision of this Agreement is ruled invalid or unenforceable by a court of competent jurisdiction because of the conflict between such provision and any applicable law or public policy, it is the intent of the parties that such provision shall be modified by the Court to the extent appropriate to render the provision reasonable valid and enforceable.  If any court of competent jurisdiction shall at any time deem the duration of the restrictions of Section 6, the “Area” as defined in Section 6, or any provisions of Section 6 unenforceable, the duration of the applicable restrictions set forth in Section 6 shall be deemed to be the longest duration permissible by law under the circumstances, the “Area” shall be deemed to comprise the largest territory permissible by law under the circumstances, and the remainder of the Agreement shall nevertheless stand.  The court in each case shall reduce the aforementioned provisions to permissible duration or territory.

 

Section 14.                                      Miscellaneous.  This Agreement constitutes the entire understanding between the parties concerning the Officer’s employment with the Company and supersedes any and all previous agreements between the Officer and the Company concerning such employment.  Except for judicial modification as set forth in Section 13, this Agreement cannot be amended or modified in any respect, unless such amendment or modification is evidenced by a written instrument signed by both the Company and the Officer.  The captions of the various sections of this Agreement are not a part of the context hereof, are inserted merely for convenience in locating the different provisions hereof and shall be ignored in construing this Agreement.

 

The parties have executed multiple counterparts of this Agreement, each of which shall be deemed to be an original, as of the date set forth at the beginning hereof.

 

 

	
THE   COMPANY:
    	
 
    	
THE   OFFICER:
    
	
 
    	
 
    	
 
    
	
ADCARE   HEALTH SYSTEMS, INC.
    	
 
    	
MARTIN   D. BREW
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
By:   
    	
/s/   Boyd P. Gentry,
    	
 
    	
/s/   Martin D. Brew
    
	
 
    	
Boyd   P. Gentry,
    	
 
    	
Martin   D. Brew
    
	
 
    	
President   and CEO
    	
 
    	
 
    

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}]]